Nurse Practitioner in Lincoln, AL Accepting Medicare
5 Nurse Practitioner nurses found. Showing 1 - 5
 Ariel Carpenter, CRNP Nurse Practitioner - Occupational Health Medicare: Not Enrolled in Medicare Practice Location: 1800 Honda Dr, Lincoln, AL 35096 Phone: 205-355-6850 |
Amy C Ledbetter, CRNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 47344 Us Highway 78, Lincoln, AL 35096 Phone: 205-763-7848 |
Misty Lawley Ralyea, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 47344 Us Highway 78, Lincoln, AL 35096 Phone: 205-763-7848 Fax: 205-763-7235 |
 Douglas Van Wilson, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 47344 Us Highway 78, Lincoln, AL 35096 Phone: 205-763-7848 |
Brenda P Bynum, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 47344 Us Highway 78, Lincoln, AL 35096 Phone: 205-763-7848 Fax: 205-763-7235 |
News Archive
Binghamton University researchers creating 3-D printing process to help treat incurable diseases
A team of Binghamton University researchers are creating a 3-D printing process to build implantable tissues and organs to treat otherwise incurable diseases.
HealthFusion launches new Chronic Care Management module
HealthFusion, maker of MediTouch EHR, the leading cloud computing software for physicians, hospitals, and medical billing services, launched a new Chronic Care Management (CCM) module that allows for practices to track and bill patients with two or more chronic conditions.
Auxilium Pharmaceuticals' total revenues decrease 17% to $83 million in Q2 2014
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the second quarter ending June 30, 2014. The Company highlighted important corporate, commercial, regulatory and clinical development updates from the quarter.
Mini strokes warn of possible major stroke
Eighty percent of strokes are ischemic, and are caused by the narrowing of the large or small arteries of the brain, or by clots that block blood flow to the brain.
Seattle Genetics reaches milestone under collaboration agreement with MedImmune
Seattle Genetics, Inc. (NASDAQ:SGEN), announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration agreement with MedImmune, LLC, a wholly owned subsidiary of AstraZeneca. The milestone was triggered by MedImmune's initiation of a phase I clinical trial of MEDI-547, its anti-EphA2 ADC for solid tumors.
› Verified 2 days ago